High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

Tessa G Steenbruggen, Lars C Steggink, Gabe S Sonke

Research output: Contribution to journal › Article › Academic › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{6adb953881ca4c7a9b95f88017a9c632,

title = "High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply",

author = "Steenbruggen, {Tessa G} and Steggink, {Lars C} and Sonke, {Gabe S}",

year = "2020",

month = aug,

day = "1",

doi = "10.1001/jamaoncol.2020.1649",

language = "English",

volume = "6",

pages = "1300",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer-Reply

AU - Steenbruggen, Tessa G

AU - Steggink, Lars C

AU - Sonke, Gabe S

PY - 2020/8/1

Y1 - 2020/8/1

U2 - 10.1001/jamaoncol.2020.1649

DO - 10.1001/jamaoncol.2020.1649

M3 - Article

C2 - 32496508

SN - 2374-2437

VL - 6

SP - 1300

JO - JAMA Oncology

JF - JAMA Oncology

IS - 8

ER -